A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes
Clinical trial NCT07670416 · RECRUITING
Trial details
- NCT number
- NCT07670416
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-03
- Primary completion
- 2028-02-24
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.